In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

BriaCell Therapeutics (TSX:BCT) is reporting that the first metastatic breast cancer patient treated with its Bria-OTS ...

Researchers at the University of Pennsylvania have introduced lab-engineered small extracellular vesicles to target tumors in ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...

The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in ...

Scientists from the University of Pennsylvania have developed an innovative cancer treatment using small extracellular ...

Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Orion Corp. and Invenra Inc. have entered into a research collaboration to discover bispecific antibodies using Invenra’s B-Body platform.

A new advanced form of treatment for one of the deadliest cancers worldwide, pancreatic cancer, may be on its way, research ...

To stay up to date on Akari's recent developments on the Webull Corporate Connect Services Platform, current Webull users can ...